Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 4/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.44 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12788580 | 0.85 | BCAT2 (0.62) | TAAR1SMN1; SMN2KDM4ENPC1BCAT2 | |
| SCHEMBL18219783 | 0.82 | BCAT2 (0.42) | TAAR1SMN1; SMN2KDM4ENPC1ADRB2 | |
| SCHEMBL17469083 | 0.81 | NPC1 (0.64) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E | |
| SCHEMBL1553366 | 0.80 | SMN1; SMN2 (0.51) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E | |
| SCHEMBL2011966 | 0.80 | SMN1; SMN2 (0.51) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E | |
| SCHEMBL8379019 | 0.79 | TAAR1 (0.58) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E | |
| SCHEMBL8379013 | 0.79 | TAAR1 (0.58) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E | |
| SCHEMBL3649469 | 0.79 | TAAR1 (0.58) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E | |
| SCHEMBL6464765 | 0.75 | HIF1A (0.68) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E | |
| SCHEMBL30534867 | 0.75 | HIF1A (0.68) | HIF1ATAAR1SMN1; SMN2TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1657235-B1 | Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates | RANDOX LAB LTD (GB) | 2011-09-21 | — | — | EP | disclosed |
| US-7192722-B2 | Phenethanolamine-derived haptens, immunogens, antibodies and conjugates | RANDOX LABORATORIES (GB) | 2007-03-20 | — | — | US | disclosed |
| US-20060223132-A1 | uses in competitive immunoassays for the detection of ractopamine, isoxsuprine and ritodrine | RANDOX LABORATORIES LIMITED (GB) | 2006-10-05 | — | — | US | disclosed |
| EP-1657235-A2 | Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates | Randox Laboratories Ltd. (GB) | 2006-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223132-A1 | uses in competitive immunoassays for the detection of ractopamine, isoxsuprine and ritodrine | HRH3, HRH4, HRH1 | HIF1A 4255/4885TAAR1 143/4885SMN1; SMN2 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.